131696 20260217205512.0 doi 10.1210/clinem/dgad706 sideral 137259 ART-2024-137259 eng Muñoz-Cabrejas, Ainara Low-quality carbohydrate intake is associated with a higher prevalence of metabolic syndrome: The AWHS study 2024 Access copy available to the general public Unrestricted Context: The relationship between carbohydrate quality intake and metabolic syndrome (MetS) is of growing interest. Objective:We aimed to assess the association between the adherence to a dietary carbohydrate quality index (CQI) with the occurrence of MetS in a Spanish cohort of working adults. Methods: A cross-sectional study was conducted of 2316 middle-aged men, aged 50.9 (SD 3.9) years, with no previous cardiovascular disease, and pertaining to the Aragon Workers’ Health Study (AWHS) cohort. Diet was collected with a 136-item semiquantitative food-frequency questionnaire. The CQI (range 4-15) was based on: dietary fiber intake, a low glycemic index, the ratio of whole grains/total grains, and the ratio of solid carbohydrates/total carbohydrates. The higher the CQI, the healthier the diet. MetS was defined by using the harmonized National Cholesterol Education Programme–Adult Treatment Panel III (NCEP-ATP III) definition. The associations across 3-point categories of the CQI and the presence of MetS were examined using logistic regression. Results: An inverse and significant association between the CQI and MetS was found. Fully adjusted odds ratios (ORs) for MetS risk among participants in the 10- to 12-point category (second highest CQI category) was 0.64 (95% CI, 0.45-0.94), and in the 13- to 15-point category (highest category) was 0.52 (95% CI, 0.30-0.88), when compared with the 4- to 6-point category (lowest category). Participants with 10 to 12 and 13 to 15 points on the CQI showed a lower risk of hypertriglyceridemia: OR 0.61 (95% CI, 0.46-0.81), and 0.48 (95% CI, 0.32-0.71) respectively. Conclusion: Among middle-aged men, a higher adherence to a high-quality carbohydrate diet is associated with a lower prevalence of MetS. Triglyceridemia is the MetS component that contributed the most to this reduced risk. info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI19-00020 info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI19-00948 info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI20-00144 info:eu-repo/semantics/openAccess All rights reserved http://www.europeana.eu/rights/rr-f/ 5.1 2024 ENDOCRINOLOGY & METABOLISM 36 / 193 = 0.187 2024 Q1 T1 2.183 2024 Biochemistry 2024 Q1 Biochemistry (medical) 2024 Q1 Medicine (miscellaneous) 2024 Q1 Endocrinology 2024 Q1 Endocrinology, Diabetes and Metabolism 2024 Q1 Clinical Biochemistry 2024 Q1 11.5 2024 info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion Laclaustra, Martin Universidad de Zaragoza (orcid)0000-0003-3963-0846 Guallar-Castillón, Pilar Casasnovas, José Antonio Universidad de Zaragoza (orcid)0000-0002-9887-2629 Marco-Benedí, Victoria Universidad de Zaragoza Calvo-Galiano, Naiara Universidad de Zaragoza (orcid)0000-0002-1889-3746 Moreno-Franco, Belén Universidad de Zaragoza (orcid)0000-0003-0604-5042 1007 610 Universidad de Zaragoza Dpto. Medicina, Psiqu. y Derm. Area Medicina 1011 615 Universidad de Zaragoza Dpto. Microb.Ped.Radio.Sal.Pú. Área Medic.Prevent.Salud Públ. 109, 9 (2024), e1768–e1775 J. clin. endocrinol. metab. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 0021-972X 368946 http://zaguan.unizar.es/record/131696/files/texto_completo.pdf Postprint 979803 http://zaguan.unizar.es/record/131696/files/texto_completo.jpg?subformat=icon icon Postprint https://academic.oup.com/jcem/article/109/9/e1768/7492504 Texto completo de la revista oai:zaguan.unizar.es:131696 articulos driver 2026-02-17-20:25:39 ARTICLE